Grip Strength Criterion Matters: Impact of Average versus Maximum Handgrip Strength on Sarcopenia Prevalence and Predictive Validity for Low Physical Performance.
Muscle Strength Definitions Matter: Prevalence of Sarcopenia and Predictive Validity for Adverse Outcomes Using the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) Criteria.
Differences in hypertension and prehypertension among people living with and without HIV in China: role of HIV infection and antiretroviral therapy.
Serum Myostatin and IGF-1 as Gender-Specific Biomarkers of Frailty and Low Muscle Mass in Community-Dwelling Older Adults.
A Phase 1 randomized study compare the pharmacokinetics, safety and immunogenicity of HLX02 to reference CN- and EU-sourced trastuzumab in healthy subjects.
Development of a Brief Caregiver-centric Screening Tool to Identify Risk of Depression among Caregivers of Hospitalized Older Adults.
Fragility fracture discriminative ability of radius quantitative ultrasound: a systematic review and meta-analysis.
Case for Validated Instead of Standard Cut-Offs for SARC-CalF...Bahat G, Oren MM, Yilmaz O, et al. Comparing SARC-F with SARCCalF to screen sarcopenia in community-dwelling older adults. Journal of Nutrition, Health, & Aging 2018; 22(9):1034-1038
Measurement of leakage neutron spectra for aluminium with D-T fusion neutrons and validation of evaluated nuclear data
Bifunctional biomorphic SiC ceramics embedded molten salts for ultrafast thermal and solar energy storage
FP04.03 Dynamic Liquid Biopsy for Selecting Advanced NSCLC Patients for Primary Tumor Resection After Targeted Therapy.
The protective effect of ligustrazine on rats with cerebral ischemia–reperfusion injury via activating PI3K/Akt pathway.
Effects of aging, baseline renal function and stage of HIV infection on post‐treatment changes in renal function among HIV‐infected patients: a retrospective cohort study.
Vitamin D‐supplemented yogurt drink reduces Candida infections in a paediatric intensive care unit: a randomised, placebo‐controlled clinical trial.
Identification and diagnosis of Secondary Progressive Multiple Sclerosis during the clinical encounter: Results from a physician survey
Mid-Treatment Apparent Diffusion Coefficient Predicts Late Xerostomia following Head and Neck Cancer Radiotherapy.